Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07720349

Digital Long-term Follow-up of Patients With Coronary Artery Disease: a Randomized Controlled Trial

The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sørlandet Hospital Arendal, Arendal, Norway

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

>18 years of age, survived a recent (<30 days) AMI and/or PCI, access to a smartphone or tablet, signed written informed consent

Exclusion criteria

patient does not understand Norwegian

Treatment and study plan

"HeartCheck"

Device

a digital application developed specifically for patient support during follow-up after acute myocardial infarction or PI for stable coronary artery disease

Primary outcomes

  1. The proportion of patients fulfilling all of the following evidence-based goals for risk factor control at 1 year follow-up: 1) BP< 130/80 mmHg, 2) LDL-cholesterol <1.4 mmol/l, 3) HbA1c<53 mmol/mol, and 4) No smoking.

    Time frame: 12 months after inclusion in the study

Study contacts

Contact information is provided by the study sponsor or research team.

Ida O Nilsen

CONTACT

Sigrun Halvorsen

CONTACT

[email protected]

+4722119101

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Collaborators

  • Sorlandet Hospital HF

Registry information

Official study title

Digital Long-term Follow-up of Patients With Coronary Artery Disease

Acronym: HeartCheck

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
Jul 22, 2026
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.